You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Vivitrol

Showing 1 - 25 of 100
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Opioid Use Disorder Trial in Philadelphia (Buprenorphine injection, Naltrexone Injection)

Recruiting
  • Opioid Use Disorder
  • Buprenorphine injection
  • Naltrexone Injection
  • Philadelphia, Pennsylvania
    Addiction Treatment Center, University of Pennsylvania
Feb 1, 2023

Opioid-use Disorder Trial in New York (Naltrexone 380 MG)

Active, not recruiting
  • Opioid-use Disorder
  • Naltrexone 380 MG
  • New York, New York
    Columbia University Medical Center
Jul 1, 2022

Opioid-use Disorder Trial in Tustin (BICX104, Vivitrol)

Recruiting
  • Opioid-use Disorder
  • Tustin, California
    Orange County Research Center
Jul 18, 2022

Opioid-use Disorder Trial in New York (Buprenorphine, Naltrexone, Vivitrol)

Terminated
Has Results
  • Opioid-use Disorder
  • New York, New York
    New York State Psychiatric Institute
Feb 4, 2022

Opioid Dependence, Alcohol Dependence Trial (Vivitrol Injectable Product, IVL3004)

Not yet recruiting
  • Opioid Dependence
  • Alcohol Dependence
  • (no location specified)
Nov 10, 2022

Heroin Dependence Trial in New York (Buprenorphine/naloxone)

Terminated
  • Heroin Dependence
  • New York, New York
    New York State Psychiatric Institute
Feb 4, 2022

Opiod Use Disorder Trial in Adelaide (Combination Product: Naltrexone)

Recruiting
  • Opiod Use Disorder
  • Combination Product: Naltrexone
  • Adelaide, South Australia, Australia
    CMAX
Apr 7, 2022

Covid19 Trial in Saint Louis Park, Saint Paul (Colchicine 0.6 mg, Naltrexone)

Completed
  • Covid19
  • Saint Louis Park, Minnesota
  • +1 more
Jan 10, 2023

Immune Activation and Cardiovascular Risk in HIV

Active, not recruiting
  • HIV Infection
  • +2 more
  • Cleveland, Ohio
  • +1 more
Sep 20, 2022

Opioid-use Disorder Trial in Loerenskog (Extended release naltrexone)

Completed
  • Opioid-use Disorder
  • Extended release naltrexone
  • Loerenskog, Akershus, Norway
    Akershus University Hospital
Nov 30, 2022

Opioid-use Disorder Trial in New York (Vivitrol, Buprenorphine)

Completed
Has Results
  • Opioid-use Disorder
  • New York, New York
    New York State Psychiatric Institute
May 25, 2022

Alcohol Use Disorder Trial in Houston (Lemborexant 10 mg, Naltrexone)

Not yet recruiting
  • Alcohol Use Disorder
  • Houston, Texas
    The Menninger Clinic
Aug 11, 2022

Opioid-use Disorder Trial in Providence (buprenorphine/naloxone oral product, injectable naltrexone, Pharmacy maintenance

Active, not recruiting
  • Opioid-use Disorder
  • buprenorphine/naloxone oral product
  • +3 more
  • Providence, Rhode Island
    Rhode Island Hospital
Aug 21, 2022

Opioid Dependence Trial (Brixadi, Vivitrol)

Not yet recruiting
  • Opioid Dependence
  • (no location specified)
Feb 11, 2022

Opioid Dependence Trial in Lexington (XR-NTX community location)

Completed
  • Opioid Dependence
  • XR-NTX community location
  • Lexington, Kentucky
    University of Kentucky
Apr 4, 2022

Alcohol Use Disorder, Substance Use, Alcohol Abuse or Dependence Trial in San Francisco (Vivitrol (Extended Release Naltrexone))

Completed
  • Alcohol Use Disorder
  • +2 more
  • Vivitrol (Extended Release Naltrexone)
  • San Francisco, California
    University of California, San Francisco
Aug 3, 2022

Heroin Dependence, Opioid Dependence Trial in Philadelphia (Naltrexone)

Completed
  • Heroin Dependence
  • Opioid Dependence
  • Philadelphia, Pennsylvania
    Center for the Studies of Addiction
Feb 11, 2022

Alcohol Use Disorder, Alcoholism Trial in Philadelphia (XR-NTX 380 mg, intramuscular injection, Medical Management, Placebo

Recruiting
  • Alcohol Use Disorder
  • Alcoholism
  • XR-NTX 380 mg, intramuscular injection
  • +2 more
  • Philadelphia, Pennsylvania
    University of Pennsylvania Center for Studies of Addiction
Jun 6, 2022

Alcohol Use Disorder Trial (injectable naltrexone, oral naltrexone)

Not yet recruiting
  • Alcohol Use Disorder
  • injectable naltrexone
  • oral naltrexone
  • (no location specified)
Feb 23, 2022

Melanoma, Prostate Cancer, Renal Cancer Trial in Providence (Naltrexone)

Terminated
Has Results
  • Melanoma
  • +2 more
  • Providence, Rhode Island
    Miriam Hospital
Feb 23, 2022

Alcohol Dependence, Alcohol Use Disorder Trial in New York (XR-NTX+CM (Extended-Release Naltrexone plus Care Management))

Completed
Has Results
  • Alcohol Dependence
  • Alcohol Use Disorder
  • XR-NTX+CM (Extended-Release Naltrexone plus Care Management)
  • New York, New York
    Bellevue Hospital Center
Apr 18, 2022

COVID-19, Acute Respiratory Distress Syndrome, Severe Acute Respiratory Syndrome (SARS) Trial in Royal Oak (Naltrexone,

Terminated
Has Results
  • COVID-19
  • +3 more
  • Royal Oak, Michigan
    William Beaumont Hospital
Jan 12, 2022

Drug Dependence Trial in Baltimore (Extended Release Naltrexone, Psychosocial Treatment, Buprenorphine)

Completed
Has Results
  • Drug Dependence
  • Extended Release Naltrexone
  • +2 more
  • Baltimore, Maryland
  • +1 more
Oct 13, 2021

Cannabis Use Disorder Trial in Toronto (Naltrexone 380 MG [Vivitrol], Motivational Enhancement Therapy and Cognitive Behavioral

Not yet recruiting
  • Cannabis Use Disorder
  • Naltrexone 380 MG [Vivitrol]
  • Motivational Enhancement Therapy and Cognitive Behavioral Therapy
  • Toronto, Ontario, Canada
    Centre for Addiction and Mental Health
Sep 24, 2020

Cocaine Dependence Trial in United States (Buprenorphine + Naltrexone, Placebo + Naltrexone)

Completed
Has Results
  • Cocaine Dependence
  • Buprenorphine + Naltrexone
  • Placebo + Naltrexone
  • Los Angeles, California
  • +10 more
Oct 1, 2021